Rights and permissions
About this article
Cite this article
Costs of end-stage renal disease “extremely high” in the US. Pharmacoecon. Outcomes News 422, 8 (2003). https://doi.org/10.1007/BF03276552
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276552